ENUFIFE Trademark

Trademark Overview


On Monday, July 28, 2014, a trademark application was filed for ENUFIFE with the United States Patent and Trademark Office. The USPTO has given the ENUFIFE trademark a serial number of 86349898. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 4, 2022. This trademark is owned by Glaxo Group Limited. The ENUFIFE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
enufife

General Information


Serial Number86349898
Word MarkENUFIFE
Filing DateMonday, July 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 4, 2022
Registration Number4793212
Registration DateTuesday, August 18, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, March 4, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, August 18, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 18, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 3, 2015ASSIGNED TO LIE
Tuesday, March 31, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, October 12, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, October 12, 2014LETTER OF SUSPENSION E-MAILED
Sunday, October 12, 2014SUSPENSION LETTER WRITTEN
Saturday, October 11, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 31, 2014NEW APPLICATION ENTERED IN TRAM